Amanda Molkara

Amanda Molkara serves as a Contracting Officer at the Naval Medical Logistics Command (N62645), where she plays a critical role in securing mission-critical medical logistics capabilities for U.S. Navy and Marine Corps forces worldwide. She manages the full lifecycle of acquisitions for advanced diagnostic equipment, analytical laboratory instruments, and point-of-care medical systems essential to combat casualty care and preventive medicine operations. Her portfolio emphasizes rapid procurement cycles to support global operational readiness, ensuring that field-deployable medical technologies meet stringent DoD performance and interoperability standards. Molkara works closely with technical stakeholders to translate clinical requirements into precise solicitation language and contract deliverables. Molkara’s contracting patterns reflect a preference for open, unrestricted competition, with no set-asides applied to her portfolio. She engages primarily with established manufacturers and technology integrators capable of delivering high-reliability medical hardware and diagnostic systems under strict quality assurance protocols. Her working relationships are characterized by a focus on technical compliance, supply chain resilience, and post-award performance monitoring to ensure sustained operational support in austere environments. Her procurement activities are concentrated in two primary NAICS categories: 334516 for analytical laboratory instrument manufacturing and 621512 for diagnostic imaging centers. These reflect her specialization in procuring sophisticated medical diagnostics, including portable spectrometers, molecular testing platforms, and imaging systems designed for field use. Her technical expertise lies at the intersection of clinical medicine and defense logistics, ensuring acquired systems are ruggedized, maintainable, and compatible with military medical networks. Molkara’s contracting approach prioritizes technical capability and mission necessity over socioeconomic set-asides, consistently awarding under full and open competition. While she does not currently utilize 8(a), HUBZone, or SDVOSB programs, her focus remains on acquiring mission-critical capabilities from vendors with proven expertise in defense-grade medical technology.